Product Information
CLARITHROMYCIN 250 MG/5 ML SUS is a generic product labeled by Sandoz Inc., priced at $1.5659 per ML under NDC 00781602352. Its NADAC has been published 575 times since Nov 28, 2013.
FDA first approved this application on Sep 4, 2007.
Strength
250 mg/5mL
Manufacturer
Sandoz Inc.NDC
00781602352
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLARITHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA065283FDA Approved
9/4/2007
On Market Since
9/4/2007
Pharmacological Classes
Price Statistics
The NADAC for CLARITHROMYCIN 250 MG/5 ML SUS has been published 575 times since Nov 28, 2013, and over the history we have for it it has risen 116.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5659 per ML |
|---|---|
| All-time high | $1.6034 (Dec 10, 2025) |
| All-time low | $0.6078 (Jul 20, 2016) |
| 52-week high | $1.6034 |
| 52-week low | $1.4454 |
| Median price | $1.3025 |
| Average price | $1.2040 |
| Largest weekly change | +40.2% (Aug 17, 2016) |
| Weeks tracked | 575 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clarithromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLARITHROMYCIN 250 MG/5 ML SUS?
The current National Average Drug Acquisition Cost (NADAC) for CLARITHROMYCIN 250 MG/5 ML SUS, manufactured by Sandoz Inc., is $1.5659 per ML (NDC 00781602352), effective Sep 30, 2026.
How has the price of CLARITHROMYCIN 250 MG/5 ML SUS changed over time?
Over the history we have for it, the NADAC for CLARITHROMYCIN 250 MG/5 ML SUS has risen 116.0%. It has been tracked across 575 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLARITHROMYCIN 250 MG/5 ML SUS?
Since Nov 28, 2013, the NADAC for CLARITHROMYCIN 250 MG/5 ML SUS has ranged from a low of $0.6078 (Jul 20, 2016) to a high of $1.6034 (Dec 10, 2025), with a median of $1.3025 per ML.
Are there cheaper alternatives to CLARITHROMYCIN 250 MG/5 ML SUS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLARITHROMYCIN 250 MG/5 ML SUS, is $1.3454 per ML — about 14% below CLARITHROMYCIN 250 MG/5 ML SUS.
Who manufactures CLARITHROMYCIN 250 MG/5 ML SUS?
CLARITHROMYCIN 250 MG/5 ML SUS (NDC 00781602352) is labeled by Sandoz Inc., and CMS classifies it as a generic product.